UC HEALTH LINE: Attention Guys--Testicular Cancer Isn t as Rare as You Think
Each year, nearly 8,000 American menmany between the ages of 20 and 39are diagnosed with testicular cancer. And in most cases, the disease is first detected by self-examination.
Oncology experts at the University of Cincinnati (UC) Barrett Cancer Center at University Hospital want to encourage Cincinnati men to understand their risk for this disease and pay attention to changes in the size, shape and feeling (dull aches or heaviness) of their testiclesespecially men between the ages of 20 and 39, the most common age of disease onset.
In early December, 20-year-old
Unfortunately, according to news reports, Potokar ignored early warning signs and was diagnosed after the cancer spread to his lungs and abdomen. He underwent surgery on Dec. 4 and is currently receiving chemotherapy in
William Barrett, MD, says Potokar is a perfect example of who should be especially cognizant of his risk for testicular cancer. And he says the disease is very treatable.
Testicular cancer represents one of the only home runs in oncology in that a cure is frequently possible with the treatments available todayeven in advanced disease, explains Barrett, who is an associate professor of radiology at UC and director of radiation oncology at the Barrett Cancer Center.
Most people perceive testicular cancer to be uncommon, but its not that rare so men still need to recognize the warning signs, he says. Testicular cancer is often very curable, but can be fatal if left untreated.
According to the National Cancer Institute, testicular cancer accounts for about 1 percent of all cancer in men, and is more common in men under 40.
Symptoms include a lump, swelling or enlargement of the testicle and/or pain or discomfort in a testicle.
Barrett says most testicular cancers are found during self-exams, but some symptoms are not obvious enough to be detected without a physical exam by a physician.
The good news is that testicular cancer has a five-year survival rate of 97 percent, he says. But any man who notes a testicular mass or enlargement should immediately consult his physician. Delaying a check-up could result in a longer, more difficult recovery.
Men who have a family history of testicular cancer or personal history of cryptorchidism (pronounced kript-OR-kid-izm and often referred to as undescended testicles) could be at an increased risk for the disease. According to the American Cancer Society (ACS), however, only 14 percent of testicular cancers occur in men with cryptorchidism, leading experts to believe this condition is not a direct cause of the disease. White American men are five to 10 times more likely to get testicular cancer than are African-American men, according to ACS.
To learn more about testicular cancer, visit www.netwellness.org, a collaborative health-information Web site staffed by
The
UC Health Barrett Cancer Center is a patient-care facility for cancer and a core component of the UC Cancer Institute.
Related Stories
UC radiation oncologist speaks with Local 12 news about clinical trial for head and neck cancer treatment
August 10, 2026
Dr. Sara Medek, a UC radiation oncology professor, speaks with Local 12 news about a new clinical trial aimed at reducing radiation in certain areas while still treating cancer effectively but with fewer painful side effects.
Cancer Center director charts future based on collaboration, AI
August 10, 2026
David Gius, MD, PhD, was featured in a Cincinnati Business Courier article and The Cancer Letter’s “The Directors" podcast discussing his priorities and goals as he recently took the helm as director of the University of Cincinnati Cancer Center.
UC graduates cross finish line at commencement
August 7, 2026
The University of Cincinnati recognized 2,125 graduates in two ceremonies at summer commencement Friday on campus at Fifth Third Arena.